Following the UK’s triggering of Article 50 to leave the European Union, the HPRA, together with medicines agencies in Europe, is making preparations to ensure that they continue to deliver on their patient and animal health remit even if the UK fully exits the current systems on 29 March 2019.
The HPRA wishes to engage with stakeholders to explain how the organisation is responding to the possible implications of Brexit and hear from them the key issues and concerns they have.
The aim of the meeting is to engage with stakeholders on their approach to potential Brexit scenarios, to outline their plans to increase their contribution to EU regulatory procedures as may be required, and to understand the concerns and requirements of different stakeholder groups.
Speakers will include representatives from human and veterinary medicines industry associations, from the Industrial Development Authority and the HPRA.
Manufacturers, distributors, and marketing authorisation holders operating in Ireland or the UK and those companies who may wish to develop a presence in Ireland.
The event takes place on Thursday 31 August, 2017 at the Crowne plaza Hotel, Santry from 13.30 – 16.00 with registration from 13.00.
There is no fee to attend this event.
To register please use the following link – http://www.eiseverywhere.com/brexit